NCT06449404Recruiting
7.0T Magnetic Resonance Imaging Study of Parkinson's Disease
Source: ClinicalTrials.gov · Last updated 8 Nov 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This clinical trial study is conducted to detect the imaging characteristics of the patients with Parkinson's diseases (PD) by 7-Tesla (7T) magnetic resonance imaging (MRI).
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 200 (estimated)
- First submitted
- 14 Mar 2022
- Start date
- 1 Mar 2022
- Primary completion date
- 1 Jul 2027
- Lead sponsor
- Chinese PLA General Hospital
- Diseases
- Parkinson disease
- NCT number
- NCT06449404
What you commit to
- Study type: Observational
- Planned participants: 200
- From 1 Mar 2022 to the primary completion date, 1 Jul 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- the patients with brain disorders such as cerebrovascular disease, brain tumors, epilepsy, other neurodegenerative disease;
- psychiatric disorders with impaired cognitive function;
Other
- contraindications to MRI.
Who the study is looking for
- the patients with PD who was diagnosed by the experienced neurologist specializing in movement disorders
Age in the registry: 18 years to 80 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Chinese PLA General Hospital Coordinator of this site? Confirm its status | Beijing | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.